JAVIER
SASTRE VALERA
Profesor asociado de Ciencias de la Salud
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (6)
2019
2018
-
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
European Journal of Cancer, Vol. 101, pp. 263-272
-
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer
International Journal of Cancer, Vol. 143, Núm. 8, pp. 1954-1962
2016
-
Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1072-1081
2015
-
Clinical guideline SEOM: hepatocellular carcinoma
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 988-995
-
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy
Molecular Diagnosis and Therapy, Vol. 19, Núm. 6, pp. 397-408